Vimian, a global animal health company covering four areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services, has announced its intention to raise up to approximately SEK1.633bn (US$160m) via a rights…
Sweden: Vimian announces plans rights issue to finance M&A
…
…






